Search research articles
Contact Us
Filters
Showing results (951-960 of 1,009) with videos related to
Page
of 101
Sort By:
International Journal of Stroke : Official Journal of the International Stroke Society
|
September 14, 2018
Clinical prediction of thrombectomy eligibility: A systematic review and 4-item decision tree
Gaia T Koster, T Truc My Nguyen, Erik W van Zwet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 28, 2019
Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers
Jonathan Z Li, Florencia P Segal, Ronald J Bosch, et al.
Nature Communications
|
February 20, 2026
Q4ddPCR: a flexible, 4-target assay for high-resolution HIV reservoir profiling
Rachel Scheck, Mark Melzer, Gregory Gladkov, et al.
Plos Computational Biology
|
April 13, 2019
Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size
Daniel I S Rosenbloom, Peter Bacchetti, Mars Stone, et al.
The Journal of Infectious Diseases
|
May 28, 2014
Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection
Netanya G Sandler, Xinyan Zhang, Ronald J Bosch, et al.
Open Forum Infectious Diseases
|
August 8, 2022
Toward Ending the HIV Epidemic: Temporal Trends and Disparities in Early ART Initiation and Early Viral Suppression Among People Newly Entering HIV Care in the United States, 2012-2018
Jun Li, Elizabeth Humes, Jennifer S Lee, et al.
AIDS (London, England)
|
December 21, 2022
The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007-2017
Raynell Lang, M John Gill, Sally B Coburn, et al.
Journal of the American College of Cardiology
|
September 21, 2019
Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin
John W Eikelboom, Jacqueline J Bosch, Stuart J Connolly, et al.
Frontiers in Cellular and Infection Microbiology
|
February 28, 2022
Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients
Geoffrey T Ivison, Elena Vendrame, Giovanny J Martínez-Colón, et al.
The Lancet. Infectious Diseases
|
April 13, 2015
Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study
Marcel A Müller, Benjamin Meyer, Victor M Corman, et al.
Page
of 101
Search research articles
Search
Showing results (951-960 of 1,009) with videos related to
Sort By:
Page
of 101
International Journal of Stroke : Official Journal of the International Stroke Society
|
September 14, 2018
Clinical prediction of thrombectomy eligibility: A systematic review and 4-item decision tree
Gaia T Koster, T Truc My Nguyen, Erik W van Zwet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 28, 2019
Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers
Jonathan Z Li, Florencia P Segal, Ronald J Bosch, et al.
Nature Communications
|
February 20, 2026
Q4ddPCR: a flexible, 4-target assay for high-resolution HIV reservoir profiling
Rachel Scheck, Mark Melzer, Gregory Gladkov, et al.
Plos Computational Biology
|
April 13, 2019
Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size
Daniel I S Rosenbloom, Peter Bacchetti, Mars Stone, et al.
The Journal of Infectious Diseases
|
May 28, 2014
Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infection
Netanya G Sandler, Xinyan Zhang, Ronald J Bosch, et al.
Open Forum Infectious Diseases
|
August 8, 2022
Toward Ending the HIV Epidemic: Temporal Trends and Disparities in Early ART Initiation and Early Viral Suppression Among People Newly Entering HIV Care in the United States, 2012-2018
Jun Li, Elizabeth Humes, Jennifer S Lee, et al.
AIDS (London, England)
|
December 21, 2022
The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007-2017
Raynell Lang, M John Gill, Sally B Coburn, et al.
Journal of the American College of Cardiology
|
September 21, 2019
Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin
John W Eikelboom, Jacqueline J Bosch, Stuart J Connolly, et al.
Frontiers in Cellular and Infection Microbiology
|
February 28, 2022
Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients
Geoffrey T Ivison, Elena Vendrame, Giovanny J Martínez-Colón, et al.
The Lancet. Infectious Diseases
|
April 13, 2015
Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study
Marcel A Müller, Benjamin Meyer, Victor M Corman, et al.
Page
of 101